Slide 1: IKS - Partnership with and Investment in WWMG
IKS - Partnership with and Investment in WWMG
Slide 2: Disclaimer
Disclaimer This presentation may include opinions and assumptions about future performance which could be considered as forward-looking statements. Forward-looking statements intrinsically cover several risks and uncertainties, which may lead to a material difference between actual results and the s
Slide 3: Physician groups are struggling with declining reimbursement trends
Physician groups are struggling with declining reimbursement trends RISING COST, DECLINING THE IMPACT IS ACROSS ALL FFS REIMBURSEMENT SPECIALTIES Anesthesiology, Cardiac Surgery, MEDICARE Colorectal Surgery, Diagnostic testing -3% to - 4% facilities, Emergency medicine, PHYSICIAN PAY 9.8% Interventi
Slide 4: With current solutions not delivering the right outcomes, the market is ready for a solution that works
With current solutions not delivering the right outcomes, the market is ready for a solution that works PHYSICIAN AGGREGATION VALUE-BASED CARE IS HEALTH IT COSTS WAY MORE MODELS HAVEN’T DELIVERED STRUGGLING THAN IT DELIVERS % of Physicians employed by hospitals IMPACT ON REIMBURSEMENT 69% / health s
Slide 5: Consolidation led by PE groups and hospitals hasn't delivered the desired outcomes
Consolidation led by PE groups and hospitals hasn’t delivered the desired outcomes Often the approach has been focused on driving growth while overlooking holistic care, leading to continued high utilization and costs Mostly focused on low-hanging fruit of better payer contracts or improved supplier
Slide 6: IKS' approach is different
IKS’ approach is different 6
Slide 7: IKS is the right partner for Physician groups in driving better clinical, financial and operational outcomes
IKS is the right partner for Physician groups in driving better clinical, financial and operational outcomes REDUCTION IN OVERALL COST OF OPERATIONS With a pragmatic combination of technology and globalized human capital that delivers significant operating synergies and compounding value ENABLING BETT
Slide 8: This approach delivers tremendous value, the whole delivering more than the sum of its parts
This approach delivers tremendous value, the whole delivering more than the sum of its parts Value from components of When combined create While also delivering additive platform… accretive synergies… compounding effect Better revenue capture 8.9% 11.1% 11.7% Improved Reduced clinician operating effic
Slide 9: We are now making the leap from being a platform provider to a transformation partner
We are now making the leap from being a platform provider to a transformation partner IKS is a high cash generating business IKS 2.0 With extremely positive unit economics and IKS 3.0 low SG&A costs With a capital-light model Building the platform Becoming a Giving us the liberty to find different wa
Slide 10: Engaging in models of combining our capabilities with our capital to create deeper alignment
Engaging in 3 models of combining our capabilities with our capital to create deeper alignment with our customers LAUNCHING A UNDERWRITING INVESTING IN JV TO DRIVE GROWTH PERFORMANCE MEDICAL GROUP IN VERTICAL MARKETS OUTCOMES GROWTH Level of capital Level of capital Level of capital requirement* req
Slide 11: An investment in Western Washington Medical Group (WWMG) presents an opportunity to manifest IKS 3.0
An investment in Western Washington Medical Group (WWMG) presents an opportunity to manifest IKS 3.0 INVESTING IN WWMG as a multi-specialty group; presents an opportunity to invest in MEDICAL GROUP enabling Medical Group growth through the MSO GROWTH Level of capital requirement* This would create a
Slide 12: Western Washington Medical Group at-a-glance
Western Washington Medical Group at-a-glance $91M 30+ 31 Primary Care Providers Annual patient revenue Years of Experience (Including APPs) 90+ 20 40% Clinicians Specialties Owned by physicians 49 6 Physicians are shareholders; Primary Care Locations $18.4M reflective of a strong physician owned, phy
Slide 13: Through proven revenue enhancement solutions, cost reductions, clinician additions, and new VBC business, MSO EBITDA should increase substan
Through proven revenue enhancement solutions, cost reductions, clinician additions, and new VBC business, MSO EBITDA should increase substantially Revenue Upsides Cost Reduction Adding Clinicians Value Based Care Reduce leakages across the CBO solution reduces revenue IKS platform reduces the IKS pl
Slide 14: Transaction Structure
Transaction Structure 37.4% Revenue Share 100% Shareholding Shareholders/ Collections Providers 52% 62.6% Shareholding Revenue Share MSO 48% shareholding IKS will capture 48% of the value from EBITDA improvement in the MSO 14
Slide 15: Transaction Structure - Genesis of the MSO
Transaction Structure - Genesis of the MSO Due to Corporate Practice of Medicine regulations in Washington, IKS cannot directly invest in WWMG A Managed Services Organization (MSO) is being established to handle all non-clinical operations of WWMG WWMG + MSO WWMG will split into a dual structure Pro
Slide 16: This is a strategic investment to elevate our market position, deepen our influence and drive future growth
This is a strategic investment to elevate our market position, deepen our influence and drive future growth 1 Positions IKS to lead strategic transformation amid evolving healthcare market dynamics Advances IKS up the value chain, differentiating from commoditized point solution providers; and create
Slide 17: IKS is uniquely positioned to make a difference in the market
IKS is uniquely positioned to make a difference in the market this investment in WWMG is a great starting point 1 The large, $1.5Tn physician market presents a significant untapped efficiency potential 2 Consolidation, led by Private Equity or Hospitals, has not meaningfully impacted cost of care, qual
Slide 18: Solid track record of Return on our Strategic Investments so far
Solid track record of Return on our Strategic Investments so far Strategic Sale price/ Investment Status Investment Total ROE Investments Current Value CAGR Lightbeam Health Invested 100,000 1,300,000 1200% 33% Sift Medical Data Inc Sold 2,000,000 4,097,463 105% 94% Abridge AI Inc Invested 1,249,998
Slide 19: Join the Movement
Join the Movement Grow, Scale, Thrive